Clinical Trial Update: A Study Utilizing Escitalopram in Glioma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating escitalopram in patients with glioma and is currently recruiting at the University of Nebraska.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: University of Nebraska | Conditions: Glioma of Brain, Glioma | Phase 2 | Status: RECRUITING